Literature DB >> 28331045

Investing in a novel shorter treatment regimen for multidrug-resistant tuberculosis: to be repeated.

Mohammed A Yassin1, Ernesto Jaramillo2, Eliud Wandwalo1, Dennis Falzon3, Anna Scardigli1, Osamu Kunii1, Karin Weyer2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28331045     DOI: 10.1183/13993003.00081-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  2 in total

Review 1.  New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis.

Authors:  Denise Rossato Silva; Margareth Dalcolmo; Simon Tiberi; Marcos Abdo Arbex; Marcela Munoz-Torrico; Raquel Duarte; Lia D'Ambrosio; Dina Visca; Adrian Rendon; Mina Gaga; Alimuddin Zumla; Giovanni Battista Migliori
Journal:  J Bras Pneumol       Date:  2018-04       Impact factor: 2.624

2.  Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis.

Authors:  Jonathon R Campbell; Dennis Falzon; Fuad Mirzayev; Ernesto Jaramillo; Giovanni Battista Migliori; Carole D Mitnick; Norbert Ndjeka; Dick Menzies
Journal:  Emerg Infect Dis       Date:  2020-03-17       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.